Skip to main content

West-Ward launches first Norvir generic

3/21/2018
West-Ward Pharmaceuticals, the U.S. subsidiary of Hikma Pharmaceuticals, has introduced the first generic of Norvir (ritonavir) tablets. The company’s generic treatment for HIV in combination with other antiretroviral agents will be entitled to 180 days of market exclusivity, West-Ward said.

“We are very excited to be launching ritonavir tablets,” Hikma generics president Brian Hoffman said. “This is an exciting product which demonstrates the successful execution of our strategy to develop differentiated products. We will be launching ritonavir with additional patient support and co-pay assistance to ensure more people are able to access this life-saving medicine.”

West-Ward said that as part of the launch, it was engaging advocacy organizations to gain an understanding of the best way to support patients and providers. It also will launch an education and awareness campaign that includes a website and direct communication.

West-Ward’s generic Norvir will be available in 100-mg dosage strength. The generic Norvir is launching into a market that IQVIA data said saw $208.5 million in sales for the 12 months ended December 2017.
X
This ad will auto-close in 10 seconds